Nish Shah, MD
Sports Medicine · Richmond, TXNPI 1255775177
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Amgen accounts for 67.1% of it on its own, with 8 other manufacturers making up the rest. That places this record below the midpoint for sports medicine clinicians in TX, where the typical reported total is $1,700.
Across 48 payments — averaging $15.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$498
- IBSA Pharma Inc.$71
- Medinc Of Texas$51
- Kowa Pharmaceuticals America, Inc.$25
- Sumitomo Pharma America, Inc.$22
- Vertex$21
- plus $53 from 3 others
What the payments were for
- Food & beverage$742100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 36 | $498 |
| IBSA Pharma Inc. | 4 | $71 |
| Medinc Of Texas | 2 | $51 |
| Kowa Pharmaceuticals America, Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Vertex | 1 | $21 |
| Johnson & Johnson | 1 | $21 |
| Hydrocision, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
How this compares
$742 in reported general payments places this provider in the 35th percentile of 437 sports medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium-MisoprostolDiclofenac Sodium/Misoprostol | 20 | $2,458 |
| Celecoxib | 101 | $1,972 |
| Butalb-Acetaminoph-Caff-CodeinButalbit/Acetamin/Caff/Codeine | 12 | $1,633 |
| Gabapentin | 78 | $1,021 |
| Meloxicam | 288 | $988 |
| Naproxen | 91 | $705 |
| Rosuvastatin Calcium | 24 | $584 |
| Duloxetine Hcl | 27 | $354 |
| Etodolac | 22 | $283 |
| Tizanidine Hcl | 32 | $224 |
| Diclofenac Sodium | 18 | $207 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 31 | $187 |
| Tramadol Hcl | 61 | $186 |
| Losartan Potassium | 12 | $161 |
| Ibuprofen | 48 | $113 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Richmond
- Thomas DeberardinoSan Antonio$3.5M
- Robert ScheinbergDallas$2.2M
- Walter LoweHouston$1.4M
- Reed BartzSunnyvale$1.2M
- James GregoryHouston$565K
- John McDonaldAustin$499K
- James McKinleyTyler$305K
- Kelechi OkorohaDallas$297K
- Leon PaulosPearland$289K
- Marc LabbeThe Woodlands$238K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.